Month: June 2022

The Supportive Health Services Sector at Emirates Health Services (EHS) honored regular blood donors and all parties that support blood donation activities, in appreciation of their initiatives and efforts to promote it as a culture, as well as their active role in campaigns that helped make blood and its essential components available to patients, saving many lives in the process. H.E. Dr Abdullah Al-Naqbi asserted that: “Emirates Health Services (EHS) is committed to developing all of our healthcare services, and…

Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to AC0176 for the treatment of patients with metastatic castration resistant prostate cancer (mCRPC) with disease progression on or after treatment with androgen receptor signaling inhibitors. AC0176 is an orally bioavailable, chimeric degrader molecule targeting the androgen receptor (AR). AC0176 is currently being evaluated in a Phase 1 clinical trial…

Global life science innovator MGI Tech Co. Ltd. (MGI) and King Abdullah International Medical Research Center (KAIMRC) have signed a Memorandum of Understanding (MOU) to engage in a strategic collaboration in the fields of genomic science and biotechnology. MGI and KAIMRC will lead an international collaborative research program powered by MGI's innovative technologies in areas such as genomics and bioinformatics for health and diseases while driving the development of local talent in these fields. Driven by MGI's proprietary DNBSEQ™ technology*,…

Globally, Chronic illnesses pose a major socioeconomic burden. Research indicates that one in every three adults worldwide lives with more than one form of chronic illness, incurring considerable costs for both the individual and on healthcare systems, at large. Through their Connected Care Program, The Health Bank Global (THB) have modernized remote health monitoring by making patients an active part of their healthcare journey. By harnessing such methods, patients facing chronic conditions are able to monitor their own symptoms and…

AstraZeneca's COVID-19 vaccine has been granted approval in the European Union (EU) by the European Medicine Agency (EMA) as a third dose booster in adults. Healthcare professionals can now use AstraZeneca’s COVID-19 vaccine as a third dose booster in patients previously given a primary vaccine schedule of either the AstraZeneca COVID-19 vaccine or an EU-approved mRNA COVID-19 vaccine. The authorization is based on a review by the Committee for Medicinal Products for Human Use (CHMP) of the substantial body of…